ES2133285T3 - Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta. - Google Patents

Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.

Info

Publication number
ES2133285T3
ES2133285T3 ES91909065T ES91909065T ES2133285T3 ES 2133285 T3 ES2133285 T3 ES 2133285T3 ES 91909065 T ES91909065 T ES 91909065T ES 91909065 T ES91909065 T ES 91909065T ES 2133285 T3 ES2133285 T3 ES 2133285T3
Authority
ES
Spain
Prior art keywords
water
high affinity
alpha
soluble polypeptides
beta interferons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909065T
Other languages
English (en)
Inventor
Pierre Eid
Ion Gresser
Georges Lutfalla
Francois Meyer
Knud Erik Mogensen
Michael Tovey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medisup International NV
Original Assignee
Medisup International NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25675747&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2133285(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medisup International NV filed Critical Medisup International NV
Application granted granted Critical
Publication of ES2133285T3 publication Critical patent/ES2133285T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

POLIPETIDOS HIDROSOLUBLES DOTADAS DE UNA GRAN AFINIDAD PARA LOS INTERFERONES ALFA Y BETA, SECUENCIAS DE ADN Y CELULAS DE EXPRESION, PROCESO DE PREPARACION, MEDICAMENTOS, COMPOSICIONES QUE LOS CONTIENEN Y APLICACION COMO AGENTE DE DIAGNOSTICO O DE ELABORACION DE ANTICUERPOS.
ES91909065T 1991-04-17 1991-04-17 Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta. Expired - Lifetime ES2133285T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002085469A CA2085469C (fr) 1991-04-17 1991-04-17 Polypeptides hydrosolubles ayant une haute affinite pour les interferons .alpha. et .beta.
PCT/FR1991/000318 WO1992018626A1 (fr) 1991-04-17 1991-04-17 POLYPEPTIDES HYDROSOLUBLES AYANT UNE HAUTE AFFINITE POUR LES INTERFERONS α ET $g(b)

Publications (1)

Publication Number Publication Date
ES2133285T3 true ES2133285T3 (es) 1999-09-16

Family

ID=25675747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909065T Expired - Lifetime ES2133285T3 (es) 1991-04-17 1991-04-17 Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.

Country Status (12)

Country Link
US (1) US6475983B1 (es)
EP (1) EP0537166B1 (es)
JP (1) JPH05507614A (es)
KR (1) KR0172969B1 (es)
AT (1) ATE181961T1 (es)
AU (1) AU653937B2 (es)
CA (2) CA2085469C (es)
DE (1) DE69131426T2 (es)
DK (1) DK0537166T3 (es)
ES (1) ES2133285T3 (es)
GR (1) GR3031369T3 (es)
WO (1) WO1992018626A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (en) 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of interferon -alpha/beta binding protein
US5821078A (en) 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
AU4411699A (en) * 1998-06-05 1999-12-20 Human Genome Sciences, Inc. Interferon receptor hkaef92
AU3725600A (en) * 1999-03-02 2000-09-21 Maxygen, Inc. Surrogate orphan ligands for orphan receptors
BR0206364A (pt) * 2001-01-09 2005-08-16 Baylor Res Inst Métodos para tratar doenças auto-imunes em um indivìduo e testes diagnósticos in vitro
US20050176108A1 (en) * 2003-03-13 2005-08-11 Young-Min Kim Physiologically active polypeptide conjugate having prolonged in vivo half-life
US20040180054A1 (en) * 2003-03-13 2004-09-16 Hanmi Pharm. Co., Ltd. Physiologically active polypeptide conjugate having prolonged in vivo half-life
ATE555133T1 (de) 2003-11-13 2012-05-15 Hanmi Holdings Co Ltd Igg fc fragment für einen arzneimittelträger und verfahren zu dessen herstellung
NZ547157A (en) 2003-12-10 2009-07-31 Medarex Inc Interferon Alpha Antibodies and their uses
WO2006086586A2 (en) * 2005-02-10 2006-08-17 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
US7888481B2 (en) * 2005-02-10 2011-02-15 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
US7732167B2 (en) * 2005-06-17 2010-06-08 Regeneron Pharmaceuticals, Inc. Interferon-α/β binding fusion proteins and therapeutic uses thereof
MX2010012052A (es) * 2008-05-07 2010-12-14 Novo Nordisk As Anticuerpos humanizados contra interferon-alfa humano.
KR101934923B1 (ko) 2009-11-02 2019-04-10 유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 치료학적 뉴클레아제 조성물 및 방법
PH12013502441B1 (en) 2011-04-29 2019-02-08 Univ Washington Therapeutic nuclease compositions and methods
PL3063275T3 (pl) 2013-10-31 2020-03-31 Resolve Therapeutics, Llc Terapeutyczne fuzje nukleaza-albumina i sposoby
JP7308034B2 (ja) 2016-07-01 2023-07-13 リゾルブ セラピューティクス， エルエルシー 最適化二重ヌクレアーゼ融合物および方法
BR112020003670A2 (pt) * 2017-08-22 2020-09-01 Sanabio, Llc receptores de interferon solúveis e usos dos mesmos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516515A (en) * 1986-02-05 1996-05-14 Interferon Sciences, Inc. Separation of alpha interferon receptor proteins and antibodies therefor
US5216128A (en) * 1989-06-01 1993-06-01 Yeda Research And Development Co., Ltd. IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
US5889151A (en) * 1989-10-20 1999-03-30 Societe Leb-Tech Purified human alpha interferon receptor
FR2657881A1 (fr) * 1990-02-05 1991-08-09 Europ Biotechnologie Lab Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides.
US5218090A (en) * 1990-06-12 1993-06-08 Warner-Lambert Company EGF receptor truncates
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE

Also Published As

Publication number Publication date
JPH05507614A (ja) 1993-11-04
EP0537166B1 (fr) 1999-07-07
DK0537166T3 (da) 1999-11-22
GR3031369T3 (en) 2000-01-31
EP0537166A1 (fr) 1993-04-21
DE69131426T2 (de) 2000-01-27
CA2085469C (fr) 2007-07-31
CA2585487A1 (fr) 1992-10-29
WO1992018626A1 (fr) 1992-10-29
AU653937B2 (en) 1994-10-20
CA2085469A1 (fr) 1992-10-18
US6475983B1 (en) 2002-11-05
AU7792791A (en) 1992-11-17
ATE181961T1 (de) 1999-07-15
DE69131426D1 (de) 1999-08-12
KR0172969B1 (ko) 1999-02-01

Similar Documents

Publication Publication Date Title
ES2133285T3 (es) Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
DE59101397D1 (de) O-glycosyliertes ifn-alpha.
NO20003286D0 (no) 11<beta>-halogen-7<alfa>-substituerte østratriener, fremgangsmÕte for fremstilling av farmasøytiske preparater inneholdende angitte 11<beta>-halogen-7<alfa>-substituerte østratriener, og anvendelse av disse for fremstilling av medikamenter
MX9101008A (es) Composicion para la fabricacion de peliculas,que contiene polihidroxiacidos y compatibilizadores y procedimiento para la preparacion de dichas peliculas
FI920664A7 (fi) Menetelmä hammas- ja sairaanhoidon alalla käytettävien restauraatioide n, proteesien tai vastaavien valmistamiseksi
DK0429624T3 (da) Radioimmunterapi under anvendelse af alfa-partikelemission
ATE83663T1 (de) Imipramin enthaltende arzneizubereitungen.
MX9200324A (es) Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene.
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE69012702D1 (de) Dentalzusammensetzung.
MX9102580A (es) Nuevas benzodiacepinonas, procedimiento para su preparacion y composicion farmaceutica que las contiene.
MX9302927A (es) Nuevos peptidos, la preparacion y utilizacion de los mimos.
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
IT8921108A0 (it) Siringa utilizzabile una sola volta.
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
CA2070647A1 (en) Use of an anticoagulant as a diagnostic agent
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
DK578589A (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
MX9203616A (es) Derivados de 4-amidino cromano y de 4-amidino[3,2-c] piridina y composiciones farmaceuticas que los contienen.
ES2089091T3 (es) Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.
MX23878A (es) Copolimero que contiene vinil acetato, composicion que lo contiene y procedimiento para la preparacion del mismo.
DE69003003D1 (de) Pharmazeutische Zusammensetzung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537166

Country of ref document: ES